IDEXX > Companion Animal > Education and Events > Diagnostic Edge Newsletter
 

diagnositc edge logo        October 2005 Issue
 /

Featured Case Study:
Two-year-old spayed, female, mixed-breed dog, Teddi
by Daniel F. Hogan, DVM, DACVIM and Dennis B. DeNicola, DVM, PhD, DACVP
Announcing the NEW bile acids test for the IDEXX SNAP® Reader
2006 IDEXX SNAP Up the Savings, enroll by October 31, 2005
Tips for optimizing efficacy of treatment of ear mites with ACAREXX®
Quick Tip—Urine sample collection on a cat
Featured IDEXX Webinar, teleconference and seminars
Interactive Challenge! And answers from last month...
Results of last month's survey
 
 
Newsletter Archive
Subscribe now
Download/Print (458 KB)
Our world-class customer support is now available 24 hours a day, 7 days a week in the United States and Canada.

Toll-free: 1-800-248-2483
 

Education

Featured Case Study: Two-year-old spayed, female, mixed-breed dog, Teddi
Daniel F. Hogan, DVM, DACVIM, Associate Professor of Cardiology, Purdue University School of Veterinary Medicine and Dennis B. DeNicola, DVM, PhD, DACVP, Chief Veterinary Educator, IDEXX Laboratories

Teddi

History

Teddi travels between Indiana, Texas and Arizona frequently. Vaccinations are current. She had two puppies at one year and three puppies three months prior to this presentation. She was spayed after her second litter. Teddi had an episode of assumed gastritis that resolved six months prior to this presentation.

Interpretive Summary

hematology lab data

figure 1 Erythron—There is a high-normal red blood cell mass associated with slight microcytosis (decreased MCV). Moderate numbers of target cells are present (see Figure 1) and there is a suggestion of microcytosis as well as hypochromasia on the peripheral blood film. Since there is no significant anemia or polychromasia present, developing iron deficiency is unlikely in this case. Because of the lack of hypercholesterolemia (see below), the likelihood of an upset plasma phospholipids-to-cholesterol ratio and “lipid loading” onto the erythrocyte membrane is high. Hepatic dysfunction should be high on the differential, however, consideration for various nonspecific metabolic disease, as well as possible splenic disease, should be included in the differential based solely upon these hematologic changes. Specifically, investigation into possible hepatic vascular shunt and insufficiency is warranted since microcytosis not associated with iron deficiency is a relatively restrictive finding in the dog.

Although the physical examination did not reveal dehydration and the total protein of the plasma by refractometry does not support dehydration, consideration for some subclinical dehydration must be made based upon the finding of a high within-reference-range erythrocyte mass. This change could also be explained by slight erythrocytosis associated with a compensatory process if there is any cardiac insufficiency (bradycardia noted clinically).

Leukon—No significant quantitative or qualitative leukocyte abnormalities are noted.

Thrombon—The platelet count is minimally outside the reference-range limit, which is well within the third standard of deviation from the clinically normal animal population; this is interpreted to be normal. Platelets are morphologically normal.

chemistry report

Liver panel—Primary abnormalities are noted in the liver panel. There is evidence of mild-to-moderate hepatocellular injury with the increased ALT. The increase in ALKP is extremely minimal and very nonspecific. There is no other support for cholestatic disease. Hepatic insufficiency is suggested with the decreased glucose, BUN and cholesterol. However, since other causes for these abnormalities are possible, additional specific liver-function testing should be considered. The present findings of hepatocellular injury and suggested insufficiency, along with the microcytosis, are strongly supportive of a hepatic vascular anomaly, which requires confirmation with other diagnostics. See the results of the liver-function tests.

Acid-base status—The finding of decreased chloride relative to sodium is supportive of a metabolic alkalosis with either loss or sequestration of chloride. The observed clinical sign of intermittent vomiting is most likely associated with some loss of chloride and is the source of this electrolyte abnormality. The potential of alkalemia and associated decreased extracellular potassium should be considered to explain the hypokalemia. However, decreased intake associated with the anorexia can also explain the hypokalemia. The high sodium may be related to subclinical dehydration. The finding of a high within-reference-range carbon dioxide level in the face of metabolic alkalosis suggests the possibility of a slight metabolic acidosis (with simple metabolic alkalosis an increase in total carbon dioxide is commonly seen to maintain electroneutrality in the face of the decreased chloride). The slight out-of-reference-range anion gap suggests a possible titrational metabolic acidosis. Further evaluation of the acid-base status through blood gas analysis and blood pH determination should be considered if these electrolyte changes are not corrected during the course of this disease process.

Protein panel—Although there are no out-of-reference-range abnormalities, the finding of a low within-reference-range total protein and albumin in the face of high within-reference-range erythrocyte mass, and in an animal with intermittent vomiting and diarrhea, is unusual. The potential of subclinical dehydration and false-raising of the albumin, resulting in both a within-reference-range albumin and total protein should be considered. Any further characterization of protein abnormalities would require serum protein electrophoresis (SPE). Specific SPE changes have been reported associated with hepatic insufficiency and, if other laboratory testing proves inconclusive, evaluation of the SPE profile in this animal should be considered.

Calcium—The slightly decreased total calcium value is well within the third standard deviation outside of the reference range and is considered clinically insignificant. Some of this change may be related to the low within-reference-range albumin value. Approximately 50% of total calcium is albumin-bound and not physiologically functional. If there were any clinical signs associated with hypocalcemia, measuring an ionized calcium would be warranted.

Amylase—The minimally low amylase has absolutely no clinical significance. Decreases in most enzyme activities in routine serum chemistry profiles have no clinical significance for day-to-day patient evaluation.

urinalysis report
Urinalysis—The finding of a hyposthenuric urine sample in a dog with potential subclinical dehydration is of concern and this should be re-evaluated with repeated urinalysis examinations. No significant abnormalities are noted in the sediment.

additional diagnosis report
Liver-function tests—The resting high ammonia level, as well as the pre- and post-bile acid increases, support the presence of hepatic insufficiency. Further evaluation should include detailed diagnostic imaging with particular attention to the possibility of vascular shunt disease, as well as possible liver biopsy for further characterization of hepatic disease pending evaluation for vascular shunts.

Diagnostic Imaging
Routine radiology—Standard radiographic evaluation of the abdomen in this case revealed microhepatica, which is supportive of possible vascular shunt, but is not diagnostic for shunt or helpful in characterizing the type of shunt, if present.

Ultrasonography—Detailed ultrasonographic evaluation of the abdomen in this case could not confirm the presence of a vascular shunt; however, there were several supportive findings beyond the previously observed microhepatica that suggested vascular shunt.

Mesenteric portogram—A mesenteric portogram was performed after Teddi was stabilized to help confirm the presence of a vascular shunt. In this case, a single extrahepatic vascular shunt was identified.

portograms

Portograms provided by Brian Poteet, MS, DVM, DACVR, DABSNM, Director of Diagnostic Imaging, Gulf Coast Veterinary Specialists, Houston, TX.

Diagnosis
Single extrahepatic portosystemic shunt

Clinical Case Outcome
Surgical correction of this single extrahepatic shunt included the placement of a 3.5-mm ameroid ring around the portosytemic shunt vessel. The ameroid ring slowly occluded the shunt vessel over the following six- to eight-week period, which lessened the risk of hypertension that could be seen after surgery. Teddi recovered from surgery without complications and was monitored closely in the intensive care unit for five days postoperatively. Teddi was released with instructions for restricted activity for two weeks and a recheck CBC and chemistry profile in twelve weeks. Teddi has responded well to this procedure.

We want to hear from you. Let us know what you think about this case and any other case topics that you would like to see. E-mail us at diagnosticedge@idexx.com.

The recommendations contained in Diagnostic Edge educational materials are intended to provide general guidance only. As with any diagnosis or treatment, you should use clinical discretion with each patient based on a complete evaluation of the patient, including history, physical presentation and complete laboratory data. With respect to any drug therapy or monitoring program, you should refer to product inserts for a complete description of dosages, indications, interactions and cautions.

 

back to the top    

product news
Announcing the NEW bile acids test for the IDEXX SNAP® Reader
Add bile acids to your in-house testing menu to expand your liver-function testing capabilities.

The IDEXX VetLab® system offers you the flexibility to test what you want when you want, and the ability to use the liver-function test best suited to your patients’ needs. The IDEXX VetTest® Chemistry Analyzer already provides flexibility in evaluating liver enzymes and the ability to run ammonia to determine liver function. By adding the SNAP® Bile Acids Test for the IDEXX SNAP® Reader to your in-house testing, you will expand your liver-function testing capabilities, giving you the most comprehensive in-house diagnostics for liver testing.  

bile acids SNAP test View the
bile acids white paper
. (184 KB)

bile acids SNAP testBile Acids
Now it is possible to test for decreased liver function with the easy-to-use, in-house SNAP® Bile Acids Test for the IDEXX SNAP Reader. The IDEXX SNAP Reader has expanded its menu to include bile acids in addition to the T4 and cortisol testing capabilities that are already available. With quick results, you can begin treatment or rule out impairment during the patient visit.

For more information about the IDEXX SNAP Bile Acids Test and other IDEXX products, call 1-800-355-2896 or e-mail diagnosticedge@idexx.com.

2006 IDEXX SNAP Up the Savings
Earn credit while saving money on SNAP® 3Dx® or Heartworm test kits that help you provide thorough patient care everyday!

NEW THIS YEAR! Your savings are credited to you in Practice Developer™ points, which you can use to redeem toward any IDEXX product or service, including special members-only offers on diagnostic instruments, educational tools and much more.

Enroll in the new program with a three-kit order of SNAP 3Dx or Heartworm tests beginning September 20, 2005. If you enroll by October 31, 2005, you can earn $50 of Practice Developer™ points immediately, just for enrolling!

Send us an e-mail by October 31, 2005 to enroll. Include your name, practice name, address and telephone number.

 

back to the top    

quick tip
Tips for Optimizing the Efficacy of Treatment of Ear Mites with ACAREXX®

ACAREXX® (0.01% ivermectin) Otic Suspension is a nongreasy, premeasured suspension that is indicated for the treatment of ear mites in cats and kittens four weeks of age or older. Since the formulation is water-based, you avoid sending the patient home coated with greasy residue that is common with other ear mite treatments. The patented WISDOM™ delivery system allows the acitve ingredient, ivermectin, to be effective at a very low concentration. The WISDOM delivery system creates a "once-and-done" treatment process that couldn't be easier on the patient or the client. Since its introduction, ACAREXX has been administered to well over 1,000,000 kittens and cats.

Tips to optimize the efficacy of treatment:

  • Confirm your diagnosis of ear mites either by direct visual examination within the ear canal or by swabbing the ear and observing the sample for mites under a microscope.
  • It is not necessary to clean or flush the ears prior to treatment. If excessive debris is present, simply wipe the outer surface of the ear canal to cosmetically remove the debris prior to treatment.
  • Take an ampule from the foil pouch and shake it well to evenly disperse the active ingredient.
  • Gently squeeze the entire contents of the ampule into the ear.
  • Massage the base of the ear to distribute the solution within the ear canal.
  • Repeat the procedure for the other ear.
  • catDon't forget to treat all pets in the household to prevent potential reinfestations.
  • While a single treatment is usually successful, a repeat treatment can be administered in three weeks to eliminate severe infestations or reinfestations from another pet.

For more information about ACAREXX® (0.01% ivermectin) Otic Suspension and other IDEXX products, call 1-800-355-2896 or
e-mail diagnosticedge@idexx.com.

Refer to the package insert for complete instructions.

 

back to the top    

quick tip
Urine Sample Collection on a Cat

An easy way to collect a urine sample from a cat is to replace your cat's litter with clean Styrofoam® packing peanuts (shipping material). The peanuts don't absorb the urine.

 

back to the top    

Training Opportunities
Education and Events

We offer a variety of training events about emerging trends and best practices in veterinary diagnostics. The forums are designed to involve, educate and motivate you and your staff. Here are some of the educational events in October. View a full list of events.

Webinar
webcast Webcast

Or to register, copy and paste this Web address into your browser:
http://livemeeting.viewcentral.com/reg/IDEXX/DE

Teleconference

Seminars

Visit the education and event calendar, click the date to view the details, fill out and submit the form to register.

* This course meets the requirements for 1 hour of continuing education credit in jurisdictions that recognize AAVSB’s RACE approval; however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

AAVSB Provider Number 106

 

back to the top    

interactive challenge
Can you identify these cells?

Test your hematology knowledge by identifying the four cells in this peripheral blood film.

blood filmBackground: intact eight-year-old female German shorthaired pointer with the clinical presentation of two days of acute onset depression, lethargy and vaginal discharge. The CBC revealed a moderate leukocytosis (WBC = 46,500/µL) and minimal anemia (Hct = 35.6%).

Identify the four structures indicated in the image provided.

Send your answer in an e-mail to: diagnosticedge@idexx.com, by October 15, 2005. Please include your name, practice name, address and telephone number.

The names of the first 10 respondents to identify all four cells correctly will appear in the next issue of the Diagnostic Edge.

Winners and answers from last months's interactive challenge!
The following people were the first 10 to answer at least three out of the four senior care questions correctly and are the winners of last month’s interactive challenge. Congratulations!

Dr. Andrew M. Silverstone, Animal Care Center, Virginia Beach, Virginia, United States
Jeanne Schmidt RVT, Bel Air Veterinary Hospital, Bel Air, Maryland, United States
Gail S. Wolfe, DVM, Bennett Road Animal Clinic, Okemos, Michigan, United States
Dr. Karen Blakeley, All Pets Veterinary Clinic, Macomb, Illinois, United States
Dr. Anne De Graaf, Highland Animal Hospital, Highland, Indiana, United States
Dr. Jen Emerson, Adel Veterinary Clinic, Adel, Iowa, United States
Dr. Chung-Lin Yu, Ho-Yuan Animal Hospital, Taoyuan City, Taoyuan County, Taiwan, ROC
Dr. Deborah A. LaPaugh, LaPaw Animal Hospital, Bend, Oregon, United States
Dr. Scott Douglas Reed, Creekside Veterinary Associates, Middleburg, Florida, United State

The correct answers to these questions were:

1.

Which of the following tests should you include in a senior care profile?

Urine P:C Ratio SNAP® FIV/FeLV Test Comprehensive chemistry panel
Complete CBC Electrolytes T4
Urinalysis Parasitic disease screen  
 
Answer: all

 
2.

You suspect that a senior patient has arthritis. Which of the above tests will you run to determine if NSAIDs are safe to administer?

 
  Answer: CBC, comprehensive chemistry panel and urinalysis
 
3.

After baseline testing and the initial administration of an NSAID, how often should your patient be tested to monitor its health status (based on manufacturers' recommendations)?

 
  Answer: 7–14 days after initial dosage and every 6–12 months following
 
4.

On the recheck, which tests are you running and why?

 
  Answer: CBC, comprehensive chemistry panel and urinalysis to check blood composition, liver and kidneys

 

back to the top    

survey resuls
September Survey ResultsHere is what you said...

chart 1

chart 2

chart 3

chart 4

 

back to the top    

 

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.